CSL 1.51% $306.60 csl limited

Ann: Half Year Results Analyst Presentation, page-189

  1. 4,445 Posts.
    lightbulb Created with Sketch. 340
    "im trying to convince myself not to sell..." - This is worth a read: CSL and Australia’s biggest lottery ticket

    "Management expects net profit of US$1,480–1,550m in 2018, up around 13%, for a forward price-earnings ratio of 33 at current exchange rates.
    Undoubtedly, CSL is one of the priciest healthcare stocks around, but making the case that it’s overvalued is more difficult. With formidable competitive advantages, a dominant market position, economies of scale, and lottery tickets in CSL-112 and China, we’re sticking with HOLD."
 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.